During clinical trials, histological assessments continue to be important. Biopsies taken from patients can be analyzed to assess how the drug is affecting the target tissue. For example, in cancer trials, histological examination of tumor biopsies can help determine whether the drug is effectively reducing tumor size or altering the tumor microenvironment. This information is invaluable for adjusting treatment protocols and optimizing therapeutic outcomes.
